✦ LIBER ✦

SLN (Solid Lipid Nanoparticles) as drug carrier for an IV administration of poorly water soluble drugs

✍ Scribed by A. Dingler; S. Runge; R.H. Müller

Book ID: 117628785
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 152 KB
Volume: 4
Category: Article
ISSN: 0928-0987
DOI: 10.1016/s0928-0987(97)86382-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Solid lipid nanoparticles (SLNs) to impr

Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs

✍ LianDong Hu; Xing Tang; FuDe Cui 📂 Article 📅 2004 🏛 Pharmaceutical Press 🌐 English ⚖ 407 KB

Lipid nanoparticles for the delivery of

Lipid nanoparticles for the delivery of poorly water-soluble drugs

✍ Heike Bunjes 📂 Article 📅 2010 🏛 Pharmaceutical Press 🌐 English ⚖ 189 KB

SLN (Solid Lipid Nanoparticles), a novel

SLN (Solid Lipid Nanoparticles), a novel formulation for the oral administration of drugs

✍ S. Runge; W. Mechnert; R.H. Müller 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Solid Dispersion as an Approach for Bioa

Solid Dispersion as an Approach for Bioavailability Enhancement of Poorly Water-Soluble Drug Ritonavir

✍ Shilpi Sinha; Mushir Ali; Sanjula Baboota; Alka Ahuja; Anil Kumar; Javed Ali 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 371 KB

Design of Lipid-Based Formulations for O

Design of Lipid-Based Formulations for Oral Administration of Poorly Water-Soluble Drug Fenofibrate: Effects of Digestion

✍ Kazi Mohsin 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 409 KB

Design of lipid-based formulations for o

Design of lipid-based formulations for oral administration of poorly water-soluble drugs: Precipitation of drug after dispersion of formulations in aqueous solution

✍ Kazi Mohsin; Michelle A. Long; Colin W. Pouton 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB

This study was designed to investigate the precipitation of a lipophilic drug following dispersion of lipid formulations in water. The model drug fenofibrate was formulated in representative lipid delivery systems designed for oral administration, using medium chain glycerides, polysorbates, and pro